Literature DB >> 3117223

The myelodysplastic syndromes.

A Jacobs.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3117223      PMCID: PMC1247457          DOI: 10.1136/bmj.295.6597.553-b

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


× No keyword cloud information.
  6 in total

1.  Effect of 13-cis-retinoic acid on survival of patients with myelodysplastic syndrome.

Authors:  R E Clark; A Jacobs; C J Lush; S A Smith
Journal:  Lancet       Date:  1987-04-04       Impact factor: 79.321

2.  Role of retinoids in differentiation and carcinogenesis.

Authors:  M B Sporn; A B Roberts
Journal:  Cancer Res       Date:  1983-07       Impact factor: 12.701

3.  13-cis retinoic acid treatment of myelodysplastic syndromes.

Authors:  G Kerndrup; K Bendix-Hansen; B Pedersen; J Ellegaard; P Hokland
Journal:  Leuk Res       Date:  1987       Impact factor: 3.156

4.  Myeloid surface antigen abnormalities in myelodysplasia: relation to prognosis and modification by 13-cis retinoic acid.

Authors:  R E Clark; S A Smith; A Jacobs
Journal:  J Clin Pathol       Date:  1987-06       Impact factor: 3.411

5.  Influence of prolactin and growth hormone on rat mammary tumors induced by N-nitrosomethylurea.

Authors:  D P Rose; J J Noonan
Journal:  Cancer Res       Date:  1982-01       Impact factor: 12.701

6.  Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid.

Authors:  T R Breitman; S E Selonick; S J Collins
Journal:  Proc Natl Acad Sci U S A       Date:  1980-05       Impact factor: 11.205

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.